Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases

Margarita M. Ivanova(Lysosomal and Rare Disorders Research and Treatment Center), Özlem Göker-Alpan(Lysosomal and Rare Disorders Research and Treatment Center)
PLoS ONE
January 11, 2019
10.1371/journal.pone.0210617
Cited by 78

Related Papers

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial
|Journal of Inherited Metabolic Disease|2019|137
The definition of neuronopathic Gaucher disease
|Journal of Inherited Metabolic Disease|2020|102
Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
|PLoS ONE|2021|17
Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses
|Proteome Science|2011|11